Stifel lowered the firm’s price target on Altria Group (MO) to $68 from $72 and keeps a Buy rating on the shares. EPS of $1.30 was flat to the prior year in Q4 and in line with the firm’s estimate, but the underlying operating performance was softer than expected with higher operating costs in both the Smokable and Oral Products businesses, the analyst tells investors. Initial 2026 guidance bracketed consensus, but is second half weighted, the analyst added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MO:
- Altria Earnings Call: Cash Returns Amid Structural Headwinds
- Midday Fly By: Microsoft, Meta diverge after earnings
- Altria Files 2025 Consolidated Financial Statements Highlighting Leverage
- Altria Expands Board, Names Mancuso Director and CEO
- Altria Group sees FY26 adjusted EPS $5.56-$5.72, consensus $5.59
